{"id":1897,"date":"2021-02-24T13:10:53","date_gmt":"2021-02-24T13:10:53","guid":{"rendered":"https:\/\/meditrial.net\/clinical-trials-where\/?page_id=1897"},"modified":"2022-07-07T18:14:31","modified_gmt":"2022-07-07T18:14:31","slug":"georgia","status":"publish","type":"page","link":"https:\/\/meditrial.net\/clinical-trials-where\/eastern-europe\/georgia\/","title":{"rendered":"Georgia"},"content":{"rendered":"
<\/span><\/div>

Georgian Approval Process<\/h2>\n

Georgia has relatively short timelines for study approval procedure.
\nClinical study start-up time: 2.5 \u2013 3 months (the shortest approval timeline in Europe).<\/p>\n

Georgian Recruitment Potential<\/h2>\n

Over 230 studies have been registered under the official clinical trial registry in Georgia (41% in cardiovascular diseases, 37 % in oncology, 12% in neurology and 10 % in other therapeutic areas). Patients are generally compliant and willing to participate in clinical trials due to limited access to novel therapies.
In addition to the vast patient population, the na\u00efve patient population is significantly higher than other European nations.<\/p>\n

Investigators and Sites<\/h2>\n

The majority of sites are located in the largest cities with Tbilisi, the capital, hosting the largest and most modern hospitals with expertise in all therapeutic areas. Sites and PIs specialized in cardiovascular diseases are considered the most experienced ones.<\/p>\n<\/div><\/div>